LIGAND PHARMACEUTICALS (LGND) Institutional Shareholders

LIGAND PHARMACEUTICALS (LGND) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $4.40B in LGND holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of LGND tracked by InsiderSet, reporting ownership valued at approximately $591.35M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $865.00M, representing an estimated gain of +46.28% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 49% of the total disclosed LGND value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Vanguard Portfolio Management Llc, Congress Asset Management Co, and several other long-term asset managers with concentrated positions in LIGAND PHARMACEUTICALS (LGND).

This page ranks the largest institutional LGND shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

374

Total Reported Value

$4.40B

Largest Holder

Blackrock, Inc.

Largest Position

$591.35M

Insider Transactions (90d)

40

Latest Filing Quarter

Q2 2026

New Institutional Positions

78

Funds Exiting Positions

0

Page 1 of 8
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.01%2,961,923$591,347,927$864,999,993+$273,652,066+46.28%
Vanguard Portfolio Management Llc0.01%1,100,267$219,668,307$321,321,975+$101,653,668+46.28%
Congress Asset Management Co1.28%659,911$208,591,268$192,720,408-$15,870,860-7.61%
Janus Henderson Group Plc0.10%1,009,891$201,622,937$294,928,568+$93,305,631+46.28%
Chicago Capital, Llc4.21%553,435$174,935,212$161,625,157-$13,310,055-7.61%
Vanguard Capital Management Llc0.00%848,089$169,320,969$247,675,912+$78,354,943+46.28%
Invesco Ltd.0.03%823,604$164,432,539$240,525,312+$76,092,773+46.28%
State Street Corp0.01%778,856$155,498,600$227,457,106+$71,958,506+46.28%
Stephens Investment Management Group Llc1.61%475,609$150,335,249$138,896,852-$11,438,397-7.61%
Fmr Llc0.01%596,127$119,016,815$174,092,929+$55,076,114+46.28%
Nomura Asset Management International Inc.0.20%573,312$114,462,000$167,430,036+$52,968,036+46.28%
Franklin Resources Inc0.03%573,177$114,434,772$167,390,611+$52,955,839+46.28%
Geode Capital Management, Llc0.01%558,934$111,608,727$163,231,085+$51,622,358+46.25%
Dimensional Fund Advisors Lp0.02%425,230$84,887,195$124,184,169+$39,296,974+46.29%
Massachusetts Financial Services Co0.03%411,543$82,164,560$120,187,018+$38,022,458+46.28%
Goldman Sachs Group Inc0.01%381,111$76,088,811$111,299,656+$35,210,845+46.28%
Loomis Sayles & Co L P0.09%353,209$70,518,177$103,151,156+$32,632,979+46.28%
Deutsche Bank Ag\0.02%306,111$61,115,061$89,396,656+$28,281,595+46.28%
Victory Capital Management Inc0.04%303,224$60,538,672$88,553,537+$28,014,865+46.28%
Rice Hall James & Associates, Llc3.15%283,567$56,614,152$82,812,907+$26,198,755+46.28%
Aberdeen Group Plc0.08%172,480$54,519,204$50,371,059-$4,148,145-7.61%
Ranger Investment Management, L.P.3.87%267,943$53,494,820$78,250,074+$24,755,254+46.28%
Northern Trust Corp0.01%254,158$50,742,645$74,224,302+$23,481,657+46.28%
New York State Common Retirement Fund0.05%137,258$43,385,881$40,084,826-$3,301,055-7.61%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.01%212,888$42,503,090$62,171,812+$19,668,722+46.28%
Ashford Capital Management Inc5.12%207,565$41,440,352$60,617,283+$19,176,931+46.28%
Private Capital Management, Llc4.09%201,381$40,205,717$58,811,307+$18,605,590+46.28%
Villere St Denis J & Co Llc4.16%188,874$37,708,694$55,158,763+$17,450,069+46.28%
Charles Schwab Investment Management Inc0.01%182,887$36,513,390$53,410,319+$16,896,929+46.28%
Morgan Stanley0.00%167,229$33,387,355$48,837,557+$15,450,202+46.28%
Penn Capital Management Company, Llc2.01%100,337$31,748,435$29,302,417-$2,446,018-7.70%
Bank Of America Corp0.00%157,865$31,517,680$46,102,895+$14,585,215+46.28%
Impax Asset Management Group Plc0.21%152,444$30,435,445$44,519,746+$14,084,301+46.28%
Fiera Capital Corp0.09%135,312$27,015,040$39,516,516+$12,501,476+46.28%
Fisher Asset Management, Llc0.01%127,994$25,554,038$37,379,368+$11,825,330+46.28%
Vanguard Fiduciary Trust Co0.01%127,899$25,535,035$37,351,624+$11,816,589+46.28%
Russell Investments Group, Ltd.0.03%121,151$24,187,856$35,380,938+$11,193,082+46.28%
Bank Of New York Mellon Corp0.00%119,403$23,838,890$34,870,452+$11,031,562+46.28%
Driehaus Capital Management Llc0.17%118,169$23,592,441$34,510,075+$10,917,634+46.28%
Nomura Holdings Inc0.19%114,355$22,830,976$33,396,234+$10,565,258+46.28%
Royal Bank Of Canada0.00%111,543$22,270,000$32,575,018+$10,305,018+46.27%
Ubs Group Ag0.00%104,580$20,879,398$30,541,543+$9,662,145+46.28%
Legal & General Group Plc0.00%97,660$19,497,821$28,520,626+$9,022,805+46.28%
Next Century Growth Investors Llc1.39%95,876$19,141,643$27,999,627+$8,857,984+46.28%
Principal Financial Group Inc0.01%95,716$19,109,700$27,952,901+$8,843,201+46.28%
Clark Capital Management Group, Inc.0.11%90,206$18,009,628$26,343,760+$8,334,132+46.28%
Bank Of Montreal0.01%86,183$17,206,436$25,168,883+$7,962,447+46.28%
Wells Fargo & Company/Mn0.00%84,901$16,950,385$24,794,488+$7,844,103+46.28%
First Trust Advisors Lp0.01%80,401$16,052,059$23,480,308+$7,428,249+46.28%
D. E. Shaw & Co., Inc.0.01%78,428$15,658,150$22,904,113+$7,245,963+46.28%

Frequently asked questions about LGND

  • Who owns the most LGND stock?

    The largest holders of LGND are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LIGAND PHARMACEUTICALS (LGND).

  • Is LGND widely held by superinvestors?

    Many widely followed stocks like LGND appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LGND is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.